Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes

Area of Science:

• Hematology
• Immunology
• Clinical Diagnostics

Background:

• Immune thrombocytopenia (ITP) presents diagnostic and management challenges, particularly in predicting bleeding risk.
• Comprehensive platelet function assessment is crucial for effective ITP clinical management.

Purpose of the Study:

• To assess various platelet parameters for predicting bleeding in patients with immune thrombocytopenia (ITP).
• To evaluate the utility of platelet indices in enhancing bleeding risk prediction models for ITP.

Main Methods:

• Flow cytometry was used to quantify platelet surface proteins, reticulated platelets, and activation.
• ELISA measured soluble receptor fragments, citrullinated histone-DNA (CitH3-DNA) complexes, and thrombopoietin (TPO).
• Viscoelastography assessed whole blood clotting and platelet contribution to clot formation.

Main Results:

• ITP patients with bleeding symptoms showed elevated glycoprotein (GP) VI, Trem-like transcript-1 (TLT-1), platelet-bound immunoglobulin (Ig) G, CitH3-DNA complexes, and TPO levels.
• Reduced platelet contribution to clot formation was observed in symptomatic ITP patients.
• Multivariable analysis indicated that platelet indices significantly improved bleeding prediction compared to platelet count alone (78.1% vs. 70.48%).

Conclusions:

• Symptomatic ITP patients exhibit measurable platelet dysfunction, surface abnormalities, increased NETosis, and elevated TPO levels.
• Identifying specific biomarkers can help define clinically relevant ITP disease subsets.
• Platelet function assessment offers valuable insights for managing ITP and predicting bleeding complications.